Malignant neoplasm of breast
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Fragile X Syndrome
|
0.050 |
Biomarker
|
disease |
BEFREE |
FXR1 and FXR2 are thus likely to play important roles in the function of FMR1 and in the pathogenesis of the Fragile X Mental Retardation Syndrome.
|
7489725 |
1995 |
Squamous cell carcinoma
|
0.030 |
AlteredExpression
|
disease |
LHGDN |
Three genes, namely FXR1, CLAPM1 and EIF4G, are most frequently overexpressed in the center of the amplified domain in squamous cell carcinomas.
|
17290396 |
2007 |
Squamous cell carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Three genes, namely FXR1, CLAPM1 and EIF4G, are most frequently overexpressed in the center of the amplified domain in squamous cell carcinomas.
|
17290396 |
2007 |
Squamous cell carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Other proteins of the RNA-induced silencing complex (RISC; SND1, PACT, and FXR1) were also present at higher levels in a SCC cell line when compared with an adenocarcinoma cell line.
|
17332367 |
2007 |
Adenocarcinoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Other proteins of the RNA-induced silencing complex (RISC; SND1, PACT, and FXR1) were also present at higher levels in a SCC cell line when compared with an adenocarcinoma cell line.
|
17332367 |
2007 |
Fragile X Syndrome
|
0.050 |
Biomarker
|
disease |
BEFREE |
The Fragile X Mental retardation-Related 1 (FXR1) gene belongs to the fragile X related family, that also includes the Fragile X Mental Retardation (FMR1) gene involved in fragile X syndrome, the most common form of inherited mental retardation.
|
18628314 |
2008 |
Muscular Dystrophy, Facioscapulohumeral
|
0.030 |
AlteredExpression
|
disease |
LHGDN |
In addition, since FXR1P is an RNA binding protein likely to regulate the metabolism of muscle specific mRNAs during myogenesis, its altered expression in FSHD myoblasts may contribute to the physiopathology of this disease.
|
18628314 |
2008 |
Muscular Dystrophy, Facioscapulohumeral
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
In addition, since FXR1P is an RNA binding protein likely to regulate the metabolism of muscle specific mRNAs during myogenesis, its altered expression in FSHD myoblasts may contribute to the physiopathology of this disease.
|
18628314 |
2008 |
Intellectual Disability
|
0.020 |
GeneticVariation
|
group |
BEFREE |
The Fragile X Mental retardation-Related 1 (FXR1) gene belongs to the fragile X related family, that also includes the Fragile X Mental Retardation (FMR1) gene involved in fragile X syndrome, the most common form of inherited mental retardation.
|
18628314 |
2008 |
Mental Retardation
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The Fragile X Mental retardation-Related 1 (FXR1) gene belongs to the fragile X related family, that also includes the Fragile X Mental Retardation (FMR1) gene involved in fragile X syndrome, the most common form of inherited mental retardation.
|
18628314 |
2008 |
Muscular Dystrophy, Facioscapulohumeral
|
0.030 |
Biomarker
|
disease |
BEFREE |
FXR1P plays an important role in normal muscle development and has been implicated in facioscapulohumeral muscular dystrophy (FSHD).
|
20519410 |
2010 |
Fragile X Syndrome
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
The Fragile X-Related 1 gene (FXR1) is a paralog of the Fragile X Mental Retardation 1 gene (FMR1), whose absence causes the Fragile X syndrome, the most common form of inherited intellectual disability.
|
23555284 |
2013 |
Muscular Dystrophy, Facioscapulohumeral
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
We observed an increase of p21--a regulator of cell-cycle progression--in Fxr1-knocked-down mouse C2C12 and FSHD human myoblasts.
|
23555284 |
2013 |
Intellectual Disability
|
0.020 |
GeneticVariation
|
group |
BEFREE |
The Fragile X-Related 1 gene (FXR1) is a paralog of the Fragile X Mental Retardation 1 gene (FMR1), whose absence causes the Fragile X syndrome, the most common form of inherited intellectual disability.
|
23555284 |
2013 |
Malignant Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
Collectively, PKP1/3-associated RBPs FXR1 and UPF1 may have a functional role in prostate cancer progression and metastasis and highlight the potential importance of posttranscriptional regulation of gene expression and nonsense-mediated decay in cancer.
|
23881279 |
2013 |
Primary malignant neoplasm
|
0.030 |
AlteredExpression
|
group |
BEFREE |
Collectively, PKP1/3-associated RBPs FXR1 and UPF1 may have a functional role in prostate cancer progression and metastasis and highlight the potential importance of posttranscriptional regulation of gene expression and nonsense-mediated decay in cancer.
|
23881279 |
2013 |
Neoplasm Metastasis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Collectively, PKP1/3-associated RBPs FXR1 and UPF1 may have a functional role in prostate cancer progression and metastasis and highlight the potential importance of posttranscriptional regulation of gene expression and nonsense-mediated decay in cancer.
|
23881279 |
2013 |
Malignant neoplasm of prostate
|
0.020 |
Biomarker
|
disease |
BEFREE |
Collectively, PKP1/3-associated RBPs FXR1 and UPF1 may have a functional role in prostate cancer progression and metastasis and highlight the potential importance of posttranscriptional regulation of gene expression and nonsense-mediated decay in cancer.
|
23881279 |
2013 |
Prostate carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Collectively, PKP1/3-associated RBPs FXR1 and UPF1 may have a functional role in prostate cancer progression and metastasis and highlight the potential importance of posttranscriptional regulation of gene expression and nonsense-mediated decay in cancer.
|
23881279 |
2013 |
Fragile X Syndrome
|
0.050 |
Biomarker
|
disease |
BEFREE |
We report a functional association between lamin A and fragile X-related protein 1 (FXR1P), a protein of the fragile X-related family involved in fragile X syndrome.
|
24108105 |
2014 |
melanoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Four genes (HTR2B, FXR1, LTA4H and CDH1) demonstrated increased expression in the metastasising uveal melanomas.
|
24580015 |
2013 |
Malignant Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
Because FXR1 is overexpressed and associated with poor clinical outcomes in multiple cancers, these results have implications for other solid malignancies.
|
25733852 |
2015 |
Non-Small Cell Lung Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
FXR1 expression is a candidate biomarker predictive of poor survival in multiple solid tumors including NSCLCs.
|
25733852 |
2015 |
Tumor Progression
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Here we demonstrate that FXR1 is a key regulator of tumor progression and its overexpression is critical for nonsmall cell lung cancer (NSCLC) cell growth in vitro and in vivo.
|
25733852 |
2015 |